Can ALB's Cash Strength Fuel Greater Shareholder Returns Ahead?

Friday, Feb 27, 2026 8:56 am ET2min read
ALB--
SQM--
Aime RobotAime Summary

- AlbemarleALB-- (ALB) reported $3.2B liquidity and $692M 2025 free cash flow, driven by lithium price gains and cost controls, supporting shareholder returns.

- Peers SQMSQM-- ($1.5B liquidity) and ICLICL-- ($496M cash) also prioritize growth projects and dividends, with ICL distributing $224M in 2025 payouts.

- ALBALB-- stock surged 110.4% in six months, trading at 3.99x forward sales, with analysts forecasting 984.8% 2026 EPS growth and a "Strong Buy" Zacks Rank.

Albemarle Corporation ALB remains committed to driving shareholder value by leveraging solid liquidity and healthy cash flows. At the end of 2025, ALBALB-- had liquidity of around $3.2 billion, including cash and cash equivalents of around $1.6 billion. Its operating cash flow was around $1.3 billion in 2025, up roughly 86% from the prior-year period.

ALB generated free cash flow of $692 million for full-year 2025, driven by strong cash conversion, lower capital spending and productivity measures. ALB expects to generate meaningful free cash flow in 2026. Free cash flow is expected to be driven by the recent uptick in lithium prices, strong cash conversion and productivity. Its ability to convert improving operating performance into free cash is likely to result in incremental returns to shareholders.

The company remains focused on maintaining its dividend payout. It has raised its quarterly dividend for 30 consecutive years. ALB offers a dividend yield of 0.8% at the current stock price. Backed by healthy cash flows and sound financial health, the company's dividend is perceived to be safe and reliable.

Among its peers, Sociedad Quimica y Minera de Chile S.A. SQM exited the third quarter with strong liquidity, cash and cash equivalents being around $1.5 billion. Sociedad Quimica’s solid cash position supports its capital investment in growth projects and shareholder-friendly actions. Sociedad QuimicaSQM-- projects total capital expenditure of $2.7 billion for the 2025–2027 period, which includes the expansion of lithium carbonate and lithium hydroxide capacity in Chile, the expansion of the Mt. Holland project and investments to develop the Andover project, both in Australia.

ICL Group Ltd. ICL ended 2025 with cash and cash equivalents, and short-term investments and deposits of $496 million. ICL Group also had roughly $1.1 billion of unused credit facilities. It generated an operating cash flow of $1,056 million in 2025. ICL group distributed roughly $224 million in dividends to its shareholders last year.

ALB’s Price Performance, Valuation & Estimates

Albemarle has gained 110.4% in the past six months compared with the Zacks Chemical - Diversified industry’s rise of 1.9%.

Zacks Investment Research Image Source: Zacks Investment Research

ALB is currently trading at a forward price-to-sales ratio of 3.99, above the industry. It carries a Value Score of D.

Zacks Investment Research Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ALB’s 2026 earnings implies a year-over-year rise of 984.8%. The EPS estimates for 2026 have been trending higher over the past 60 days.

Zacks Investment Research Image Source: Zacks Investment Research

ALB stock currently carries a Zacks Rank #1 (Strong Buy).

You can see the complete list of today’s Zacks #1 Rank stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report



Albemarle Corporation (ALB): Free Stock Analysis Report

Sociedad Quimica y Minera S.A. (SQM): Free Stock Analysis Report

ICL Group Ltd. (ICL): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners. Copyright 2006-2026 Zacks Equity Research, Inc. editor@zacks.com (Manaing editor) webmaster@zacks.com (Webmaster)

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet